Financhill
Sell
36

APLS Quote, Financials, Valuation and Earnings

Last price:
$19.54
Seasonality move :
-16.64%
Day range:
$18.93 - $19.63
52-week range:
$16.10 - $42.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.13x
P/B ratio:
14.95x
Volume:
1.9M
Avg. volume:
2.2M
1-year change:
-47.84%
Market cap:
$2.5B
Revenue:
$781.4M
EPS (TTM):
-$1.79

APLS Analysts' Consensus Rating

The 18 analysts providing 12-month price projections for Apellis Pharmaceuticals shares anticipate an average target of $35.40, ranging from a low estimate of $17.00 to a high estimate of $60.00. This average target implies a growth of 81.26% compared to the current stock price of $19.53.

Consensus Price Target

$35.40

Highest Price Target

$60.00

Lowest Price Target

$17.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 11 9 9

Hold 8 9 9

Sell 0 0 0
Consensus Buy Leans Bullish Leans Bullish

APLS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Can FUBO Stock Double?
Can FUBO Stock Double?

TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…

Where Will CoreWeave Stock Be in 1 Year?
Where Will CoreWeave Stock Be in 1 Year?

When CoreWeave (NASDAQ: CRWV) slipped below its $40 IPO price…

Where Will Cisco Stock Be In 1 Year?
Where Will Cisco Stock Be In 1 Year?

Cisco Systems (NASDAQ: CSCO) rarely makes the front page of fintech…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
76
MP alert for Jul 11

MP Materials [MP] is up 51.25% over the past day.

Sell
5
RARE alert for Jul 11

Ultragenyx Pharmaceutical [RARE] is down 25.02% over the past day.

Buy
57
BGL alert for Jul 11

Blue Gold [BGL] is down 17.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock